THBD and deep vein thrombosis: Thrombomodulin levels appeared to be slightly reduced in most patients at baseline but underwent further reductions during initial treatment with thalidomide therapy with the authors thus concluding that reductions in thrombomodulin levels may have a pathogenic role in thalidomide-related thrombosis.